The 33^rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018) scheduled to take place Nov. 7-11, 2018 at the Walter E. Washington Convention Center in Washington, D.C.

Visit the SITC 2018 website today!

Click here to download a PDF brochure about SITC 2018.

Dates to Remember

• Registration and Housing open to SITC members: March 20, 2018
• Registration and Housing open to all: April 3, 2018
• Abstract submission site open: April 3, 2018
• Abstract submission site close: Aug. 1, 2018
• Late-Breaking Abstract submission site open: Aug. 24, 2018
• Late-Breaking Abstract submission site close: Sept. 13, 2018
• Early Registration ends: Oct. 10, 2018
• Housing closes: Oct. 15, 2018

Thank You to Our Organizers!

Annual Program Committee

Chair: Mario Sznol, MD – Yale School of Medicine
Susan M. Kaech, PhD – Yale University
Laura S. Wood, RN, MSN, OCN – Cleveland Clinic Taussig Cancer Center

33^rd Annual Meeting

Crystal L. Mackall, MD – Stanford University
Naiyer A. Rizvi, MD – Columbia University Medical Center
Krista M. Rubin, MS, FNP-BC – Massachusetts General Hospital
Dario A. A. Vignali, PhD – University of Pittsburgh

Workshop on Dietary Effects on the Microbiome

Laurence Zitvogel, MD, PhD – Institute Gustave Roussy

Primer on Tumor Immunology and Cancer Immunotherapy™

Timothy NJ Bullock, PhD – University of Virginia
Jonathan Powell, MD, PhD – Johns Hopkins University School of Medicine

Programming

Plenary Sessions

Cell-Based Therapies for Solid Tumors
Immune Checkpoints— Beyond PD 1
Next Generation Bispecifics and Antibody-Like Molecules
Understanding the Tumor Microenvironment

Concurrent Sessions

Advances in Immunotherapy in:

• Pediatric Malignancies
• Lung, Head and Neck Cancer
• GI and Pancreatic Cancer
• GU Tumors
• Breast and Ovarian Cancers
• Hematologic Malignancies

Basic Biology of Tregs
Clinical Management of Cell Therapy Administration
Clinical Trial Design/Surrogate Efficacy Markers
Cytokines Reinvented
Early Phase 1 Clinical Trials
Metabolic Manipulation of the TME
Myeloid Derived Suppressive Populations
Role of B cells in Immunotherapy Toxicity

Visit the SITC 2018 website to learn more.

View the SITC Meeting Code of Conduct.